NeuroSense Therapeutics Ltd - Warrants (09/11/2026) OverviewNeuroSense Therapeutics Ltd - Warrants (09/11/2026) Research & Development
Research & Development expenses for NRSNW.
Quarterly R&D Expenses
$1.25M
↓ 20.24% YoY
As of Jun 30, 2025
Annual R&D Expenses (TTM)
$4.75M
↓ 32.47% YoY
Trailing 12 months ending Jun 30, 2025